At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

JOB DESCRIPTION:

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.
Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine
We are searching for the best talent for the Associate Director, Global Medical Affairs Strategy & Execution to be in Raritan, NJ.

The Associate Director, Global Medical Affairs Execution collaborates with the Global Medical Affairs Leaders (GMAL) and Director of Global Medical Affairs Strategy and Execution to support the strategic objectives of the Global Medical Affairs function. The AD, GMA Execution will partner with the GMAL in one or more designated Therapeutic Areas/Products to lead the operational aspects of the Global Medical Affairs Function, including:

• Generation of an Integrated Evidence Generation Plan that meets prioritized regional needs
• Coordinate Medical Affairs input into product development and life-cycle management
• Facilitate Global Medical Affairs Team (GMAT) management
• Develop and execute the publication strategy/global publication plans
• Develop and execute Global Medical Affairs external insights strategies (advisory boards, pre/post congress meetings, etc.)

The AD, GMA Strategy & Execution function is accountable for:

• GMA Owned Cross-Pharma Policies and SOPs, such as Research Concept Approval Process /System, Publication SOP/System, Investigator-Initiated Studies Policy/SOPs, Collaborative Studies, Methods Review, Etc.
• GMA strategy and business planning process
• Integrated Evidence Generation Plans
• Global publication planning process
• GMA Operating Model
• GMA SharePoint Site Management/Scientific and Knowledge Information Management
• GMA Procurement Operating Procedure
• GCSO Advisory Board Business Operating Procedure

Essential functions:

• Partner with the Global Medical Affairs Leaders in preparing robust Integrated Evidence Generation Plans for compounds in development that reflect prioritized regional and local needs.
• Coordinate with the GMAL / Director of Global Medical Affairs Strategy and Execution to lead the publications process. Ensure the development of publications follows the Cross-Pharma Publication SOP. Supervise publication vendors. Coordinate publication discussions in collaboration with agency partners and J&J colleagues. Maintain the relationship with editorial staff at key journals and key scientific and academic societies.
• Oversee the successful implementation of the GMA Operating model via the Global Medical Affairs Team (GMAT) to gain regional input and alignment.
• Manage the TA/Product GMA Budget and vendors.
• Lead all aspects of the Research Concept Approval Process for Medical Affairs studies. Ensure consistent implementation of the process and conducts due diligence activities.
• Frequent interactions with GMAL, Medical Affairs directors, Janssen R&D clinical scientists, global and regional marketing directors, regulatory leaders, outcomes research and statisticians. External interactions with key opinion leaders, academic institutions, medical organizations, agencies and consultants.

QUALIFICATIONS - EXTERNAL

• A minimum of a BA/BS required. Advanced degree is preferred.
• Oncology experience is preferred.

Required Knowledge, Skills and Abilities:

• Minimum of 6 years of relevant experience required.
• Proven track record be a self-starter, goal oriented, possess excellent verbal and written communication skills, exceptional planning, and interpersonal skills, partnering, and problem solving.
• Must have the ability to multi-task and prioritize.
• Results & performance driven with strong negotiation and influencing skills.
• Demonstrated experience in managing and collaborating with internal/external partners, including outside consultants and vendors.
• Attention to detail with strong analytical skills required.
• Approximately 20% travel, both domestic and international, may be required. This position is based in Raritan, NJ.
• The ability to be in Raritan, NJ is required.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com
The anticipated base pay range for this position is $120,000 - $207,000.
Johnson & Johnson is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state or local law. We actively seek qualified candidates who are protected veterans and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act.
Johnson and Johnson is committed to providing an interview process that is inclusive of our applicants’ needs. If you are an individual with a disability and would like to request an accommodation, please email the Employee Health Support Center (ra-employeehealthsup@its.jnj.com) or contact AskGS to be directed to your accommodation resource.

The AD, GMA Strategy & Execution function is accountable for:

• GMA Owned Cross-Pharma Policies and SOPs, such as Research Concept Approval Process /System, Publication SOP/System, Investigator-Initiated Studies Policy/SOPs, Collaborative Studies, Methods Review, Etc.
• GMA strategy and business planning process
• Integrated Evidence Generation Plans
• Global publication planning process
• GMA Operating Model
• GMA SharePoint Site Management/Scientific and Knowledge Information Management
• GMA Procurement Operating Procedure
• GCSO Advisory Board Business Operating Procedur

Essential functions:

• Partner with the Global Medical Affairs Leaders in preparing robust Integrated Evidence Generation Plans for compounds in development that reflect prioritized regional and local needs.
• Coordinate with the GMAL / Director of Global Medical Affairs Strategy and Execution to lead the publications process. Ensure the development of publications follows the Cross-Pharma Publication SOP. Supervise publication vendors. Coordinate publication discussions in collaboration with agency partners and J&J colleagues. Maintain the relationship with editorial staff at key journals and key scientific and academic societies.
• Oversee the successful implementation of the GMA Operating model via the Global Medical Affairs Team (GMAT) to gain regional input and alignment.
• Manage the TA/Product GMA Budget and vendors.
• Lead all aspects of the Research Concept Approval Process for Medical Affairs studies. Ensure consistent implementation of the process and conducts due diligence activities.
• Frequent interactions with GMAL, Medical Affairs directors, Janssen R&D clinical scientists, global and regional marketing directors, regulatory leaders, outcomes research and statisticians. External interactions with key opinion leaders, academic institutions, medical organizations, agencies and consultants